Michael Hundemer

6PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.

Raphael Lutz, Florian Grünschläger, Malte Simon

|Jun 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities.

Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng

|Mar 09, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.

Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders

|Feb 18, 2021
Selective elimination of immunosuppressive T cells in patients with multiple myeloma.

Mohamed H S Awwad, Abdelrahman Mahmoud, Heiko Bruns

Pageof 1